Walleye Capital
AVEO

Walleye Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Walleye Capital’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-27,400
Closed -$410K – 4706
2022
Q4 		$410K Buy
+27,400
New +$379K 0.01% 1575

Walleye Capital's AVEO Position: Q1 2023 in Review

Walleye Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 28,589 shares — an estimated $427K sold.

Walleye Capital first reported a position in AVEO in Q2 2021 and held it in 2 quarters. The position peaked at $427K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Walleye Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Walleye Capital sold 28,589 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $427K.
  • Walleye Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
  • Walleye Capital's AVEO Pharmaceuticals, Inc. position peaked at $427K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.